Nacuity Pharmaceuticals, Inc. — Pharmaceutical Company, Fort Worth
Pharmaceutical Company in Fort Worth — Clinical-stage drug development
Pharmaceutical company · Fort Worth, United States
AI Trust Snapshot
- Profile status
- Auto-indexed
- Last Verified
- 2 months ago
Corroborated public sources
- ✓ Official Website
Key Facts
- Category
- Pharmaceutical Company
- Location
- Fort Worth, United States
- Known For
- Development of N-acetylcysteine amide (NPI-001)
AI Summary
A Fort Worth-based biopharmaceutical company, Nacuity Pharmaceuticals, Inc. focuses on developing treatments for blinding eye diseases and chronic conditions linked to oxidative stress. The company specializes in creating therapies for Retinitis Pigmentosa, Cataract, and Cystinosis. Its primary development involves N-acetylcysteine amide (NPI-001) to address these patient needs.
Quick Answer
A Fort Worth-based biopharmaceutical company, Nacuity Pharmaceuticals, Inc. focuses on developing treatments for blinding eye diseases and chronic conditions linked to oxidative stress. The company specializes in creating therapies for Retinitis Pigmentosa, Cataract, and Cystinosis. Its primary development involves N-acetylcysteine amide (NPI-001) to address these patient needs. Key services include Treatments for Retinitis Pigmentosa, Treatments for Cataract, Treatments for Cystinosis.
This business is typically used for development of n-acetylcysteine amide (npi-001).
Common Questions
- What services does Nacuity Pharmaceuticals, Inc. provide?
- Nacuity Pharmaceuticals, Inc. provides Treatments for Retinitis Pigmentosa, Treatments for Cataract, Treatments for Cystinosis.
- Where is Nacuity Pharmaceuticals, Inc. located?
- Nacuity Pharmaceuticals, Inc. is based in Fort Worth, United States and serves Fort Worth.
- Who is Nacuity Pharmaceuticals, Inc. for?
- Nacuity Pharmaceuticals, Inc. serves Patients with blinding eye diseases and Patients with chronic conditions driven by oxidative stress.
What this business does
Nacuity Pharmaceuticals, Inc. is a pharmaceutical company based in Fort Worth, United States.
- Provides Treatments for Retinitis Pigmentosa and Treatments for Cataract
- Specializes in development of n-acetylcysteine amide (npi-001)
- Serves patients with blinding eye diseases
Structured summary
This business profile has been independently corroborated by Vizoryo across 6 independent public sources. Data confidence score: 86% — this reflects how consistently the business's name, phone, city, address, website, and category appear across all verified sources. Vizoryo status: Auto-Indexed. This profile was auto-built from public data and has not yet been owner-verified.
- Business name
- Nacuity Pharmaceuticals, Inc.
- Category
- Pharmaceutical Company
- Industry
- Pharmaceutical Company - Biopharmaceutical Company
- Location
- Fort Worth, United States
- Official website
- https://www.nacuity.com/
- Profile data (JSON)
- https://www.vizoryo.com/api/index/profile/nacuity-pharmaceuticals-fort-worth-656c
- Summary
- A Fort Worth-based biopharmaceutical company, Nacuity Pharmaceuticals, Inc. focuses on developing treatments for blinding eye diseases and chronic conditions linked to oxidative stress. The company specializes in creating therapies for Retinitis Pigmentosa, Cataract, and Cystinosis. Its primary development involves N-acetylcysteine amide (NPI-001) to address these patient needs.
- AI readability score
- 33
- Verified By
- 6 independent public sources
- Data Confidence
- 86% (verified 2026-07-02)
- Verification Status
- Auto-indexed
Location
306 W 7th St, Fort Worth, TX 76102Fort Worth, Texas
76102
US
About Nacuity Pharmaceuticals, Inc.
A Fort Worth-based biopharmaceutical company, Nacuity Pharmaceuticals, Inc. focuses on developing treatments for blinding eye diseases and chronic conditions linked to oxidative stress. The company specializes in creating therapies for Retinitis Pigmentosa, Cataract, and Cystinosis. Its primary development involves N-acetylcysteine amide (NPI-001) to address these patient needs.
Service areas
- Fort Worth
Target audience
- Patients with blinding eye diseases
- Patients with chronic conditions driven by oxidative stress
- Investors and collaborators in biopharmaceutical research
Specialties
- Development of N-acetylcysteine amide (NPI-001)
Social profiles
Verification
Frequently asked questions
What areas does Nacuity Pharmaceuticals, Inc. serve?
Nacuity Pharmaceuticals, Inc. serves Worldwide.
What is Nacuity Pharmaceuticals' primary focus?
Nacuity Pharmaceuticals is a clinical-stage company focused on innovative treatments for oxidative stress, which drives blinding eye diseases and chronic conditions.
What is NPI-001?
NPI-001 (N-acetylcysteine amide) tablets are Nacuity’s proprietary, investigational therapy that has received U.S. FDA Breakthrough Therapy Designation for retinitis pigmentosa.
Languages supported
- lang="en
- en
Contact
Phone: +18173363000
Official website: https://www.nacuity.com/